These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 31653310)

  • 21. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway.
    Nechanská B; Mravčík V; Skurtveit S; Lund IO; Gabrhelík R; Engeland A; Handal M
    Addiction; 2018 Jul; 113(7):1286-1294. PubMed ID: 29443414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.
    Kraft WK; Adeniyi-Jones SC; Chervoneva I; Greenspan JS; Abatemarco D; Kaltenbach K; Ehrlich ME
    N Engl J Med; 2017 Jun; 376(24):2341-2348. PubMed ID: 28468518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of the assessment and management of neonatal abstinence syndrome.
    Bagley SM; Wachman EM; Holland E; Brogly SB
    Addict Sci Clin Pract; 2014 Sep; 9(1):19. PubMed ID: 25199822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advances in the Care of Infants With Prenatal Opioid Exposure and Neonatal Opioid Withdrawal Syndrome.
    Mascarenhas M; Wachman EM; Chandra I; Xue R; Sarathy L; Schiff DM
    Pediatrics; 2024 Jan; 153(2):. PubMed ID: 38178779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between gestational age and the severity of neonatal abstinence syndrome.
    Gibson KS; Stark S; Kumar D; Bailit JL
    Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multicenter cohort study of treatments and hospital outcomes in neonatal abstinence syndrome.
    Hall ES; Wexelblatt SL; Crowley M; Grow JL; Jasin LR; Klebanoff MA; McClead RE; Meinzen-Derr J; Mohan VK; Stein H; Walsh MC;
    Pediatrics; 2014 Aug; 134(2):e527-34. PubMed ID: 25070317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal abstinence syndrome.
    Coyle MG; Brogly SB; Ahmed MS; Patrick SW; Jones HE
    Nat Rev Dis Primers; 2018 Nov; 4(1):47. PubMed ID: 30467370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Rooming-in With Outcomes for Neonatal Abstinence Syndrome: A Systematic Review and Meta-analysis.
    MacMillan KDL; Rendon CP; Verma K; Riblet N; Washer DB; Volpe Holmes A
    JAMA Pediatr; 2018 Apr; 172(4):345-351. PubMed ID: 29404599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Outcomes of Infants with Neonatal Abstinence Syndrome.
    Maguire DJ; Taylor S; Armstrong K; Shaffer-Hudkins E; Germain AM; Brooks SS; Cline GJ; Clark L
    Neonatal Netw; 2016; 35(5):277-86. PubMed ID: 27636691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphine and Methadone for Neonatal Abstinence Syndrome: A Systematic Review.
    Slowiczek L; Hein DJ; Risoldi Cochrane Z; Gregory PJ
    Neonatal Netw; 2018 Nov; 37(6):365-371. PubMed ID: 30567886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of prenatal alcohol co-exposure on neonatal abstinence syndrome in infants born to mothers in opioid maintenance treatment.
    Kreitinger C; Gutierrez H; Hamidovic A; Schmitt C; Sarangarm P; Rayburn WF; Leeman L; Bakhireva LN
    J Matern Fetal Neonatal Med; 2016 Mar; 29(5):783-8. PubMed ID: 25758627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal abstinence syndrome: treatment and pediatric outcomes.
    Logan BA; Brown MS; Hayes MJ
    Clin Obstet Gynecol; 2013 Mar; 56(1):186-92. PubMed ID: 23314720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of neonatal abstinence syndrome in neonatal intensive care units: a national survey.
    Sarkar S; Donn SM
    J Perinatol; 2006 Jan; 26(1):15-7. PubMed ID: 16355103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of psychiatric medication co-exposure on Neonatal Abstinence Syndrome severity.
    Wachman EM; Warden AH; Thomas Z; Thomas-Lewis JA; Shrestha H; Nikita FNU; Shaw D; Saia K; Schiff DM
    Drug Alcohol Depend; 2018 Nov; 192():45-50. PubMed ID: 30205307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perinatal outcomes of Australian buprenorphine-exposed mothers and their newborn infants.
    Patel P; Abdel-Latif ME; Hazelton B; Wodak A; Chen J; Emsley F; Feller JM; Lui K; Oei JL
    J Paediatr Child Health; 2013 Sep; 49(9):746-53. PubMed ID: 23745982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buprenorphine treatment of opioid-dependent pregnant women: a comprehensive review.
    Jones HE; Heil SH; Baewert A; Arria AM; Kaltenbach K; Martin PR; Coyle MG; Selby P; Stine SM; Fischer G
    Addiction; 2012 Nov; 107 Suppl 1(0 1):5-27. PubMed ID: 23106923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newborns exposed to opioids need mothers more than NICU, say pediatricians.
    Vogel L
    CMAJ; 2018 Jan; 190(4):E123-E124. PubMed ID: 29378878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.